Scienture Holdings (SCNX) Total Current Liabilities (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Total Current Liabilities came in at $3.0 million in Q2 2026, down 60.64% year-over-year from $7.7 million in Q2 2025, and up 7.94% quarter-over-quarter from $2.8 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Total Current Liabilities (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Total Current Liabilities across 14 years of filings, most recently posting $3.0 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 60.64% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (down 60.64% YoY), while the FY2025 annual figure was $2.7 million, down 65.41% from the prior year.
- Total Current Liabilities came in at $3.0 million for Q2 2026 at Scienture Holdings, up from $2.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.6 million in Q4 2023 to a low of $1.6 million in Q1 2022.
- Average Total Current Liabilities over 5 years is $4.7 million, with a median of $3.0 million recorded in 2024.
- Year-over-year, Total Current Liabilities surged 438.31% in 2023 and plunged 65.41% in 2025.
- Over 5 years, Total Current Liabilities stood at $2.1 million in 2022, then surged by 438.31% to $11.6 million in 2023, then slumped by 31.58% to $7.9 million in 2024, then plunged by 65.41% to $2.7 million in 2025, then rose by 10.64% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $3.0 million in Q2 2026, $2.8 million in Q1 2026, and $2.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 15.65 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 6.35 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.66 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 883.19 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 4.54 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 283.66 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 331.18 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 263.21 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 12.39 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.03 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Jun 30, 2025 | 7.69 Mn |
| Mar 31, 2025 | 7.46 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 11.56 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 926,026.00 |
| Sep 30, 2021 | 654,861.00 |
| Jun 30, 2021 | 861,051.00 |
| Mar 31, 2021 | 1.24 Mn |
| Dec 31, 2020 | 842,238.00 |